Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma

NCT01268579 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

HEAD & NECK Cancer

Interventions

DRUG: ribavirin

Sponsor

Memorial Sloan Kettering Cancer Center